These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 29254741)

  • 1. Factors that affect the duration of antimicrobial therapy for cellulitis.
    Inaoki M; Inaoki A; Nishijima C
    J Infect Chemother; 2018 Apr; 24(4):256-261. PubMed ID: 29254741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors of cellulitis treatment failure with once-daily intravenous cefazolin plus oral probenecid.
    Bader MS; Twells L; Hawboldt J
    South Med J; 2011 Dec; 104(12):789-93. PubMed ID: 22089355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomised controlled trial of intravenous antibiotic treatment for cellulitis at home compared with hospital.
    Corwin P; Toop L; McGeoch G; Than M; Wynn-Thomas S; Wells JE; Dawson R; Abernethy P; Pithie A; Chambers S; Fletcher L; Richards D
    BMJ; 2005 Jan; 330(7483):129. PubMed ID: 15604157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emergency department management of home intravenous antibiotic therapy for cellulitis.
    Donald M; Marlow N; Swinburn E; Wu M
    Emerg Med J; 2005 Oct; 22(10):715-7. PubMed ID: 16189034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of cellulitis in a pediatric emergency department.
    Khangura S; Wallace J; Kissoon N; Kodeeswaran T
    Pediatr Emerg Care; 2007 Nov; 23(11):805-11. PubMed ID: 18007211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lower limb cellulitis: features associated with length of hospital stay.
    Morpeth SC; Chambers ST; Gallagher K; Frampton C; Pithie AD
    J Infect; 2006 Jan; 52(1):23-9. PubMed ID: 15907340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Palisaded neutrophilic granulomatous dermatitis caused by cellulitis in a patient with systemic lupus erythematosus.
    Misago N; Narisawa Y; Tada Y; Nagasawa K
    Int J Dermatol; 2011 Dec; 50(12):1583-5. PubMed ID: 22098012
    [No Abstract]   [Full Text] [Related]  

  • 8. A Retrospective Study on the Protective Effects of Topical Vancomycin in Patients Undergoing Multilevel Spinal Fusion.
    Gaviola ML; McMillian WD; Ames SE; Endicott JA; Alston WK
    Pharmacotherapy; 2016 Jan; 36(1):19-25. PubMed ID: 26749522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erysipelas and cellulitis: clinical and microbiological spectrum in an Italian tertiary care hospital.
    Lazzarini L; Conti E; Tositti G; de Lalla F
    J Infect; 2005 Dec; 51(5):383-9. PubMed ID: 16321649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical response at Day 3 of therapy and economic outcomes in hospitalized patients with acute bacterial skin and skin structure infection (ABSSSI).
    Amara S; Adamson RT; Lew I; Huang X
    Curr Med Res Opin; 2013 Jul; 29(7):869-77. PubMed ID: 23659559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Once or twice-daily, algorithm-based intravenous cephazolin for home-based cellulitis treatment.
    Garrett T; Harbort Y; Trebble M; Docherty T
    Emerg Med Australas; 2012 Aug; 24(4):383-92. PubMed ID: 22862755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identifying patients with cellulitis who are likely to require inpatient admission after a stay in an ED observation unit.
    Volz KA; Canham L; Kaplan E; Sanchez LD; Shapiro NI; Grossman SA
    Am J Emerg Med; 2013 Feb; 31(2):360-4. PubMed ID: 23158603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Home-based treatment of cellulitis with twice-daily cefazolin.
    Leder K; Turnidge JD; Grayson ML
    Med J Aust; 1998 Nov; 169(10):519-22. PubMed ID: 9861908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Dermatology Consultation on Outcomes for Patients With Presumed Cellulitis: A Randomized Clinical Trial.
    Ko LN; Garza-Mayers AC; St John J; Strazzula L; Vedak P; Shah R; Dobry AS; Rao SR; Milne LW; Parry BA; Kroshinsky D
    JAMA Dermatol; 2018 May; 154(5):529-536. PubMed ID: 29453872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuous cefazolin infusion to treat bone and joint infections: clinical efficacy, feasibility, safety, and serum and bone concentrations.
    Zeller V; Durand F; Kitzis MD; Lhotellier L; Ziza JM; Mamoudy P; Desplaces N
    Antimicrob Agents Chemother; 2009 Mar; 53(3):883-7. PubMed ID: 19075069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellulitis: oral versus intravenous and home versus hospital-what makes clinicians decide?
    Ibrahim LF; Babl FE; Hopper SM; Bryant PA
    Arch Dis Child; 2020 Apr; 105(4):413-415. PubMed ID: 31005895
    [No Abstract]   [Full Text] [Related]  

  • 17. Diagnosis and Management of Non-Purulent Cellulitis in the Emergency Department.
    Yadav K; Rosenberg H; Eagles D; Suh KN
    CJEM; 2019 Mar; 21(2):186-189. PubMed ID: 30892175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Once-daily intravenous cefazolin plus oral probenecid is equivalent to once-daily intravenous ceftriaxone plus oral placebo for the treatment of moderate-to-severe cellulitis in adults.
    Grayson ML; McDonald M; Gibson K; Athan E; Munckhof WJ; Paull P; Chambers F
    Clin Infect Dis; 2002 Jun; 34(11):1440-8. PubMed ID: 12015689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors predisposing to acute and recurrent bacterial non-necrotizing cellulitis in hospitalized patients: a prospective case-control study.
    Karppelin M; Siljander T; Vuopio-Varkila J; Kere J; Huhtala H; Vuento R; Jussila T; Syrjänen J
    Clin Microbiol Infect; 2010 Jun; 16(6):729-34. PubMed ID: 19694769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Who Can Have Parenteral Antibiotics at Home?: A Prospective Observational Study in Children with Moderate/Severe Cellulitis.
    Ibrahim LF; Hopper SM; Babl FE; Bryant PA
    Pediatr Infect Dis J; 2016 Mar; 35(3):269-74. PubMed ID: 26569189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.